{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T16:01:53Z","timestamp":1785859313730,"version":"3.56.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T00:00:00Z","timestamp":1747958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T00:00:00Z","timestamp":1747958400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002352","name":"Ain Shams University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002352","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To compare effectiveness and safety of transurethral diode laser vaporization of prostate (diode LVP) versus bipolar transurethral vaporization of prostate (B-TUVP) in symptomatic benign prostatic hyperplasia (BPH) patients receiving oral anticoagulants\/anti-platelet drugs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients and methods<\/jats:title>\n                    <jats:p>All symptomatic prostate patients receiving oral anticoagulants\/anti-platelet drugs are prospectively enrolled in the study between January 2023 to May 2024 in our institution. Of total 98 patients were randomized to B-TUVP (48 patients) or diode LVP (50 patients). The primary outcome is to compare B-TUVP with diode LVP regarding operative bleeding and postoperative hemoglobin drop. Secondary outcomes assess time of urinary irrigation, time of urethral catheter removal, length of hospital stays, and 6-month postoperative functional outcomes; IPSS, postoperative flow rate, and postvoid residual urine.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Baseline characteristics were similar in both groups. Diode LVP group had a significantly higher postoperative hemoglobin with a lower drop compared to B-TUVP group (p\u2009=\u20090.032, p\u2009=\u20090.007; respectively). The diode LVP group had a significantly reduced urinary irrigation duration compared to the B-TUVP group (p\u2009=\u20090.031). Also, diode LVP patients had early catheter removal compared to those in the B-TUVP group (p\u2009=\u20090.014). Additionally, the diode group had a notably reduced hospital stay duration compared to the B-TUVP group (p\u2009=\u20090.024). There were no significant differences between both groups regarding 6-month postoperative IPSS, Q max and PVRU.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Diode LVP of the prostate is a safer alternative for treating BPH with fewer risks compared to B-TUVP especially in patients receiving anticoagulants. Nonetheless, both treatments yield similar 6-months functional outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00345-025-05692-4","type":"journal-article","created":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T07:17:25Z","timestamp":1747984645000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Laser vs. bipolar prostate vaporization in bleeding-prone patients: a randomized trial and cutting-edge analysis"],"prefix":"10.1007","volume":"43","author":[{"given":"Ahmed A.","family":"Shorbagy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youssef M.","family":"Kotb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Desouki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Shabayek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4331-3715","authenticated-orcid":false,"given":"Peter","family":"Hanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,23]]},"reference":[{"issue":"6","key":"5692_CR1","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/j.eururo.2014.12.038","volume":"67","author":"C Gratzke","year":"2015","unstructured":"Gratzke C, Bachmann A, Descazeaud A, Drake MJ, Madersbacher S, Mamoulakis C et al (2015) EAU guidelines on the assessment of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol 67(6):1099\u20131109","journal-title":"Eur Urol"},{"issue":"6","key":"5692_CR2","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/j.eururo.2014.06.017","volume":"67","author":"J-N Cornu","year":"2015","unstructured":"Cornu J-N, Ahyai S, Bachmann A, de la Rosette J, Gilling P, Gratzke C et al (2015) A systematic review and meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic obstruction: an update. Eur Urol 67(6):1066\u20131096","journal-title":"Eur Urol"},{"issue":"5","key":"5692_CR3","doi-asserted-by":"publisher","first-page":"385","DOI":"10.48083\/LXOI8745","volume":"4","author":"D Perri","year":"2023","unstructured":"Perri D, Pacchetti A, Morini E, Besana U, Saredi G, Pastore AL et al (2023) Prognostic factors predicting bleeding after discharge requiring readmission after thulium laser enucleation of the prostate (ThuLEP). Soc Int Urol J 4(5):385\u2013391","journal-title":"Soc Int Urol J"},{"issue":"3","key":"5692_CR4","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.eururo.2010.06.005","volume":"58","author":"SA Ahyai","year":"2010","unstructured":"Ahyai SA, Gilling P, Kaplan SA, Kuntz RM, Madersbacher S, Montorsi F et al (2010) Meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement. Eur Urol 58(3):384\u2013397","journal-title":"Eur Urol"},{"issue":"5","key":"5692_CR5","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1016\/j.juro.2011.07.026","volume":"186","author":"L Lusuardi","year":"2011","unstructured":"Lusuardi L, Myatt A, Sieberer M, Jeschke S, Zimmermann R, Janetschek G (2011) Safety and efficacy of eraser laser enucleation of the prostate: preliminary report. J Urol 186(5):1967\u20131971","journal-title":"J Urol"},{"issue":"3","key":"5692_CR6","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.urology.2011.09.044","volume":"79","author":"H Otsuki","year":"2012","unstructured":"Otsuki H, Kuwahara Y, Kosaka T, Tsukamoto T, Nakamura K, Shiroki R et al (2012) Transurethral resection in saline vaporization: evaluation of clinical efficacy and prostate volume. Urology 79(3):665\u2013669","journal-title":"Urology"},{"issue":"6","key":"5692_CR7","doi-asserted-by":"publisher","first-page":"392","DOI":"10.4111\/icu.2018.59.6.392","volume":"59","author":"MH Mithani","year":"2018","unstructured":"Mithani MH, Khalid SE, Khan SA, Sharif I, Awan AS, Mithani S et al (2018) Outcome of 980 nm diode laser vaporization for benign prostatic hyperplasia: a prospective study. Investig Clin Urol 59(6):392\u2013398","journal-title":"Investig Clin Urol"},{"issue":"1","key":"5692_CR8","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1097\/01.ju.0000146631.14200.d4","volume":"173","author":"O Reich","year":"2005","unstructured":"Reich O, Bachmann A, Siebels M, Hofstetter A, Stief CG, Sulser T (2005) High power (80 W) potassium-titanyl-phosphate laser vaporization of the prostate in 66 high risk patients. J Urol 173(1):158\u2013160","journal-title":"J Urol"},{"issue":"3","key":"5692_CR9","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1038\/nrurol.2014.23","volume":"11","author":"M Rieken","year":"2014","unstructured":"Rieken M, Bachmann A (2014) Laser treatment of benign prostate enlargement\u2014which laser for which prostate? Nat Rev Urol 11(3):142\u2013152","journal-title":"Nat Rev Urol"},{"issue":"6","key":"5692_CR10","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1016\/j.eururo.2007.06.029","volume":"52","author":"G Wendt-Nordahl","year":"2007","unstructured":"Wendt-Nordahl G, Huckele S, Honeck P, Alken P, Knoll T, Michel MS et al (2007) 980-nm diode laser: a novel laser technology for vaporization of the prostate. Eur Urol 52(6):1723\u20131728","journal-title":"Eur Urol"},{"issue":"12","key":"5692_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0261586","volume":"16","author":"T Fukazawa","year":"2021","unstructured":"Fukazawa T, Ito H, Takanashi M, Shinoki R, Tabei T, Kawahara T et al (2021) Short-term efficacy and safety of second generation bipolar transurethral vaporization of the prostate (B-TUVP) for large benign prostate enlargement: results from a retrospective feasibility study. PLoS ONE 16(12):e0261586","journal-title":"PLoS ONE"},{"issue":"1","key":"5692_CR12","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s12874-017-0426-1","volume":"17","author":"AG O\u2019Keeffe","year":"2017","unstructured":"O\u2019Keeffe AG, Ambler G, Barber JA (2017) Sample size calculations based on a difference in medians for positively skewed outcomes in health care studies. BMC Med Res Methodol 17(1):157","journal-title":"BMC Med Res Methodol"},{"key":"5692_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013656.pub2","author":"JVA Franco","year":"2021","unstructured":"Franco JVA, Jung JH, Imamura M, Borofsky M, Omar MI, Escobar Liquitay CM et al (2021) Minimally invasive treatments for lower urinary tract symptoms in men with benign prostatic hyperplasia: a network meta-analysis. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD013656.pub2","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"5692_CR14","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1089\/end.2016.0746","volume":"31","author":"A Abou-Taleb","year":"2017","unstructured":"Abou-Taleb A, El-Shaer W, Kandeel W, Gharib T, Elshaer A (2017) Bipolar plasmakinetic enucleoresection of the prostate: our experience with 245 patients for 3 years of follow-up. J Endourol 31(3):300\u2013306","journal-title":"J Endourol"},{"issue":"4","key":"5692_CR15","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s10103-016-1883-1","volume":"31","author":"G Wu","year":"2016","unstructured":"Wu G, Hong Z, Li C, Bian C, Huang S, Wu D (2016) A comparative study of diode laser and plasmakinetic in transurethral enucleation of the prostate for treating large volume benign prostatic hyperplasia: a randomized clinical trial with 12-month follow-up. Lasers Med Sci 31(4):599\u2013604","journal-title":"Lasers Med Sci"},{"issue":"1","key":"5692_CR16","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.urols.2015.12.002","volume":"27","author":"K-Y Tzou","year":"2016","unstructured":"Tzou K-Y, Kao W-T, Lan C-Y, Ho C-H, Chiang Y-T, Chen K-C (2016) Management of prostate enlargement with acute urinary retention: diode laser vaporization in combination with bipolar transurethral resection of the prostate. Urol Sci 27(1):31\u201334","journal-title":"Urol Sci"},{"issue":"3","key":"5692_CR17","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.urology.2014.05.027","volume":"84","author":"MR Razzaghi","year":"2014","unstructured":"Razzaghi MR, Mazloomfard MM, Mokhtarpour H, Moeini A (2014) Diode laser (980 nm) vaporization in comparison with transurethral resection of the prostate for benign prostatic hyperplasia: randomized clinical trial with 2-year follow-up. Urology 84(3):526\u2013532","journal-title":"Urology"},{"issue":"3","key":"5692_CR18","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.urology.2009.09.033","volume":"75","author":"C-H Chen","year":"2010","unstructured":"Chen C-H, Chiang P-H, Chuang Y-C, Lee W-C, Chen Y-T, Lee W-C (2010) Preliminary results of prostate vaporization in the treatment of benign prostatic hyperplasia by using a 200-W high-intensity diode laser. Urology 75(3):658\u2013663","journal-title":"Urology"},{"issue":"4","key":"5692_CR19","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.euf.2019.03.002","volume":"6","author":"L Boeri","year":"2020","unstructured":"Boeri L, Capogrosso P, Ventimiglia E, Fontana M, Sampogna G, Zanetti SP et al (2020) Clinical comparison of holmium laser enucleation of the prostate and bipolar transurethral enucleation of the prostate in patients under either anticoagulation or antiplatelet therapy. Eur Urol Focus 6(4):720\u2013728","journal-title":"Eur Urol Focus"},{"issue":"3","key":"5692_CR20","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1111\/ases.13057","volume":"15","author":"T Sanjo","year":"2022","unstructured":"Sanjo T, Tanaka N, Shinojima T, Yasumizu Y, Takeda T, Matsumoto K et al (2022) Endoscopic vaporization of benign prostatic hyperplasia using a contact 980 nm diode laser under antithrombotic therapy: a prospective survey. Asian J Endosc Surg 15(3):585\u2013590","journal-title":"Asian J Endosc Surg"},{"issue":"5","key":"5692_CR21","first-page":"2355","volume":"12","author":"M Cetinkaya","year":"2015","unstructured":"Cetinkaya M, Onem K, Rifaioglu MM, Yalcin V (2015) 980-Nm diode laser vaporization versus transurethral resection of the prostate for benign prostatic hyperplasia: randomized controlled study. Urol J 12(5):2355\u20132361","journal-title":"Urol J"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-025-05692-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-025-05692-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-025-05692-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T13:55:50Z","timestamp":1767966950000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-025-05692-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,23]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5692"],"URL":"https:\/\/doi.org\/10.1007\/s00345-025-05692-4","relation":{},"ISSN":["1433-8726"],"issn-type":[{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,23]]},"assertion":[{"value":"31 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by Faculty of medicine Ain Shames Institutional Review Board No. FWA 000017585.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"322"}}